- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.02. | BioMed X Launches Pilot Project in Barbados for Black Health Equity | ||
| 20.02. | ACG Capsules Introduces Full Vegan Printed Capsules | ||
| 19.02. | Brexogen, BMI Korea Ink Exosome Therapy Licensing Deal | ||
| 19.02. | PTC's FA Drug Vatiquinone Gets FDA Priority Review | ||
| 19.02. | Biogen, Stoke Partner on Zorevunersen in Dravet Syndrome | ||
| 19.02. | Celonic Group, LINDIS Biotech Sign Manufacturing Service Agreement for Catumaxomab | ||
| 19.02. | YourBio Health Taps Paul Owen as CEO | ||
| 19.02. | FDA Grants Priority Review to Boehringer Ingelheim's NDA for Zongertinib | ||
| 18.02. | Seqens Names Pascal Villemagne as CEO | ||
| 18.02. | TekniPlex Names New CEO | ||
| 18.02. | Arcus Regains Rights to Casdatifan | ||
| 18.02. | FDA Accepts Alvotech's Eylea Biosimilar for Review | ||
| 18.02. | Asahi Kasei Bioprocess America Names New President | ||
| 18.02. | Flourish Research Acquires Diablo Clinical Research | ||
| 18.02. | sBLA for Dupixent Accepted by FDA for Priority Review | ||
| 14.02. | UniSafe Device Drives Biosimilar Success in Japan | ||
| 14.02. | Sanofi, J&J Discontinue E.mbrace Study | ||
| 14.02. | Glenmark Launches Latanoprost Ophthalmic Solution | ||
| 13.02. | Biogen 4Q Results | ||
| 13.02. | Sygnature Discovery Appoints Fraser McIntosh In Vivo Pharmacology VP | ||
| 13.02. | Nutriband and Kindeva to Co-Develop Aversa Fentanyl Abuse-Deterrent Patch | ||
| 13.02. | FDA Greenlights Roche's Evrysdi Tablet | ||
| 12.02. | Bio X Cell Introduces New Distribution Center in Beijing | ||
| 12.02. | Emmes Group Earns ISO 27001:2022 Certification for Data Security | ||
| 12.02. | SK pharmteco Launches Enhanced HPAPI Analytical Testing Lab |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
